Lucas Junginger studies inflammatory arthritis, particularly rheumatoid arthritis, a painful condition that affects the joints. His research centers on a protein known as CD13, which can enter the bloodstream and trigger inflammation in the joints by activating a receptor called B1R. By understanding how this receptor works, Junginger aims to develop treatments that can effectively reduce inflammation without compromising the overall immune response, making therapies safer for patients.
Key findings
CD13 activates the B1 receptor (B1R), leading to increased inflammation in rheumatoid arthritis, which is a major factor in disease progression.
Blocking the B1R receptor significantly reduced inflammation in human tissue samples and in mouse models, suggesting a promising therapeutic approach.
Patients with rheumatoid arthritis showed higher levels of B1R activity, indicating that targeting this receptor could directly benefit affected individuals.
Frequently asked questions
Does Dr. Junginger study rheumatoid arthritis?
Yes, he specifically focuses on the mechanisms behind rheumatoid arthritis and how to treat it effectively.
What treatments has Dr. Junginger researched?
He has researched blocking the B1 receptor as a potential treatment to reduce inflammation in rheumatoid arthritis.
Is Dr. Junginger's work relevant to inflammatory diseases?
Absolutely, his findings on CD13 and B1R may also apply to other inflammatory diseases beyond rheumatoid arthritis.
Publications in plain English
NERVE GROWTH FACTOR IS SUFFICIENT TO CAUSE MULTIPLE OSTEOARTHRITIS-RELEVANT PATHOLOGICAL FEATURES IN NAÏVE MURINE KNEE JOINTS.
2025
bioRxiv : the preprint server for biology
Obeidat AM, Newton MD, Li J, Hu B, Ishihara S +9 more
Plain English This study looked at the effects of nerve growth factor (NGF) on healthy mouse knee joints to understand its role in osteoarthritis (OA). The researchers found that repeated injections of NGF led to increased pain sensitivity, knee swelling, and changes in joint structure, such as abnormal bone growth, without causing cartilage damage. These findings are important because they highlight how NGF can mimic several features of OA, which can help in developing better treatments.
Who this helps: This helps researchers and doctors understand OA better and potentially create more effective treatments for patients suffering from the condition.
Axonal injury signaling is restrained by a spared synaptic branch.
2025
eLife
Smithson LJ, Zang JL, Junginger L, Waller TJ, Reilly-Jankowiak L +4 more
Plain English Researchers studied how injured neurons respond to damage in their axons, particularly focusing on a specific signaling pathway that affects their ability to regenerate. They found that the signaling pathway, called Wnd/DLK, is only activated when all synaptic connections are destroyed; if even a small part of the connection remains, the signaling does not kick in. This matters because understanding this process can help improve strategies for nerve repair and regeneration in the nervous system.
Who this helps: Patients with nerve injuries or conditions affecting nerve repair.
Sexual dimorphism of the synovial transcriptome underpins greater PTOA disease severity in male mice following joint injury.
2024
Osteoarthritis and cartilage
Bergman RF, Lammlin L, Junginger L, Farrell E, Goldman S +6 more
Plain English The study looked at how male and female mice respond differently to joint injuries that can lead to post-traumatic osteoarthritis (PTOA). Researchers found that male mice experienced greater joint damage and pain than females, with males showing 19% more joint-related activity and 43% lower sensitivity to pain in their hind limbs. By 28 days after the injury, only the female mice showed signs of recovering from inflammation, while males continued to have signs of ongoing inflammation and damage.
Who this helps: This research helps doctors better understand how to treat joint injuries and osteoarthritis in men and women differently.
Intra-articular sprouting of nociceptors accompanies progressive osteoarthritis: comparative evidence in four murine models.
2024
Frontiers in neuroanatomy
Obeidat AM, Ishihara S, Li J, Adamczyk NS, Lammlin L +5 more
Plain English The study looked at how pain-sensing nerves, called nociceptors, change in the knee joints of mice as osteoarthritis (OA) becomes worse. Researchers found that these nerves grow more in number in the knee during early stages of OA, especially in response to joint damage, with significant changes observed at 4 weeks and 12 weeks after injury. Understanding these changes is important because it helps explain why OA can be so painful, potentially leading to better pain management strategies in the future.
Who this helps: This helps patients suffering from osteoarthritis and their doctors.
Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis.
2023
Annals of the rheumatic diseases
Knights AJ, Farrell EC, Ellis OM, Lammlin L, Junginger LM +10 more
Plain English This study looked at how certain cells in the inner lining of joints change their roles after a joint injury, specifically focusing on fibroblasts in osteoarthritis. Researchers found seven different types of these fibroblasts, with one type (Prg4lining fibroblasts) producing a protein called R-spondin 2, which contributes to unhealthy interactions between joint cells after an injury. Understanding these changes helps clarify the mechanisms behind joint problems after injuries, potentially leading to better treatments.
Who this helps: This helps patients with post-traumatic osteoarthritis.
Patient-Perceived Outcomes Improve Faster Than Hip Strength in Recovery After Surgical Correction for Symptomatic Femoroacetabular Impingement.
2023
HSS journal : the musculoskeletal journal of Hospital for Special Surgery
Konnaris MA, Junginger LM, Sibilsky Enselman ER, Bell RD, Maerz T +1 more
Plain English This study looked at how patients recover after surgery for femoroacetabular impingement (FAI), a hip condition that causes pain and weakness. It found that while patients felt better and reported improved symptoms as early as 14 weeks after surgery, their actual hip strength didn’t show significant improvement until 26 weeks post-surgery. This is important because it highlights that patients may perceive their recovery positively before their physical strength fully returns, helping doctors better understand and manage patient expectations during recovery.
Who this helps: This helps patients recovering from hip surgery and their doctors.
Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1.
2022
The Journal of clinical investigation
Tsou PS, Lu C, Gurrea-Rubio M, Muraoka S, Campbell PL +26 more
Plain English Researchers discovered that a protein called CD13, which leaks into the bloodstream, causes inflammatory arthritis by activating a receptor called B1R found on joint cells. They confirmed this by showing that blocking B1R with drugs stopped the inflammation in multiple types of arthritis in mice and in human joint tissue samples.
This matters because B1R could be a new drug target to treat rheumatoid arthritis and other inflammatory diseases by preventing CD13 from triggering joint inflammation.
Traumatic joint injury induces acute catabolic bone turnover concurrent with articular cartilage damage in a rat model of posttraumatic osteoarthritis.
2021
Journal of orthopaedic research : official publication of the Orthopaedic Research Society
Maerz T, Newton MD, Fleischer M, Hartner SE, Gawronski K +2 more
Plain English This study looked at how a specific type of knee injury (anterior cruciate ligament rupture) affects bone and cartilage in rats. Researchers found that within two weeks after the injury, there was a significant decrease of about 15-20% in bone growth, along with a 32% increase in bone breakdown, leading to thinning of the bone and some cartilage damage. This matters because it shows how quickly joint injuries can lead to serious bone and cartilage problems, which could inform treatment and rehabilitation approaches.
Who this helps: This helps patients recovering from joint injuries and their doctors.
Cannabinoid receptor type 2 is upregulated in synovium following joint injury and mediates anti-inflammatory effects in synovial fibroblasts and macrophages.
2021
Osteoarthritis and cartilage
Rzeczycki P, Rasner C, Lammlin L, Junginger L, Goldman S +5 more
Plain English This study looked at how joint injuries affect the body’s endocannabinoid system, specifically focusing on a receptor called CB2. Researchers found that after a knee injury, there was a significant increase in CB2 levels in joint tissues, which was linked to inflammation and pain that lasted over time. Using a compound that activates CB2, they were able to reduce inflammation in both mouse and human cells, suggesting that targeting this receptor could help treat joint injuries and related pain effectively.
Who this helps: This research benefits patients with joint injuries and osteoarthritis.
Automated MicroCT-based bone and articular cartilage analysis using iterative shape averaging and atlas-based registration.
2020
Bone
Newton MD, Junginger L, Maerz T
Plain English This study focused on improving the analysis of bone and cartilage using a type of imaging called micro-computed tomography (μCT). Researchers developed an automated system that segments images of bones and cartilage more quickly and accurately than traditional manual methods, finding that using just three training images allowed for precise segmentations without errors. This is important because it means researchers can analyze preclinical data more efficiently and consistently, leading to potentially better insights into bone and joint health.
Who this helps: This benefits researchers and scientists working on bone and joint disorders.
Local and Systemic Effects of Blood Flow Restriction Therapy in an Animal Model.
2020
The American journal of sports medicine
Ramme AJ, Darcy R, Rourke BJ, Davis C, Markworth JF +4 more
Plain English In this study, researchers looked at two types of blood flow restriction therapy (BFRT) in rats to see how they affected muscle strength and growth. They found no improvements in muscle mass or strength from either therapy, but one method (repetitive restriction of muscle blood flow, or RRMBF) did result in higher growth hormone levels. This matters because it suggests that while these therapies might not enhance muscle growth or strength, there may be other hormonal effects involved.
Who this helps: This research is useful for doctors and trainers who are considering these therapies for improving muscle performance in patients or athletes.